Tag: Cancer: Prostate
ASCO: Overall Survival Up for African-American Men With mCRPC
Improved survival versus Caucasian men treated with docetaxel/prednisone, DP-containing regimen
PSA Level Three Months After Radiation Tx May Predict Outcome
Findings for men with intermediate- and high-risk prostate cancer
From 2008 to 2014, Prostate Cancer Testing, Treatment Down
Sharpest decrease seen in privately insured men after 2011
Overall, Drinking Wine Does Not Impact Prostate Cancer Risk
Findings show small increased risk with white wine, decreased risk with red wine
USPSTF: Decision to Undergo PSA Screening Should Be Individual
C recommendation for men aged 55 to 69 years; USPSTF recommends against screening for age 70+
Group Exercise, Nutrition Aids Prostate Cancer Patients on ADT
Improvements seen in mobility, body fat, muscle strength in men on androgen-deprivation therapy
Low-Dose Abiraterone Acetate Noninferior for Prostate Cancer
Low-dose AA with low-fat breakfast had greater effect on PSA; similar effect to standard dose
MRI-Targeted Biopsy Noninferior for Prostate Cancer Detection
Clinically significant cancer detected in more men in MRI-targeted biopsy versus standard-biopsy group
Dose-Escalated Radn Does Not Up Survival in Localized Prostate CA
No improvement in overall survival; no difference in cumulative rate of distant metastases
No Benefit for Aggressive Therapy in Metastatic Prostate Cancer
However, mortality higher with conservative therapy in locally advanced, non-metastatic prostate cancer
